글로벌 알레르기 천식 질환 시장 – 2029년까지의 산업 동향 및 예측

알레르기성 천식 질환 시장 분석 및 규모

글로벌 알레르기 천식 질환 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 알레르기 천식 질환 시장의 성장은 천식 질환을 유발하는 실내 및 실외 알레르겐의 높은 유병률로 인해 상승합니다. 알레르기 천식 질환 시장 성장은 전 세계적으로 COVID-19가 갑자기 발생하여 엄청난 영향을 받습니다.

 Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 알레르기성 천식 질환 시장의 성장률을 분석합니다. 글로벌 알레르기성 천식 질환 시장의 예상 CAGR은 언급된 예측 기간 동안 약 3%인 경향이 있습니다. 이 시장은 2021년에 70억 달러로 평가되었으며 2029년까지 88억 7천만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

천식이 담배 연기, 진드기, 꽃가루 또는 대기 오염과 같은 특정 알레르겐으로 인해 발생하는 경우 알레르기 천식이 발생합니다. 알레르기 천식의 전형적인 징후와 증상은 호흡곤란과 천명의 반복적인 발작입니다.           

알레르기 천식 질환 시장 범위 및 세분화

Global Allergic Asthma Disease Market Dynamics

Drivers

• Increased Clinical Acquisitions

Major market players in the industry are strategically expanding to strengthen their position in the global market. For instance, in May 2019, ASLAN Pharmaceuticals amended its license agreement with CSL Limited (CSL) with an aim to have global rights to develop, manufacture, and commercialize ‘ASLAN004’ for all types of indications. ASLAN004 is a fully human monoclonal antibody that helps trigger allergic asthma symptoms such as wheezing, exacerbations of the disease, coughing, and shortness of breath. 

• Launch of New Drugs

There has been several approvals and launch of novel drugs in the market which boost the market growth during the forecast period. For instance, Teva Pharmaceuticals Industries Limited received U.S. FDA approval in June 2017, for its two products of asthma inhalers namely; ArmonAirTM RespiClick and AirDuoTM Respiclick. These products are very much applicable for adolescent and adult patients who are suffering from asthma. The approved strength of AirDuo is 232/14 mcg, 113/14 mcg, and 55/14 mcg, whereas, the approved strengths of ArmonAir is 232 mcg, 113, mcg, and 55 mcg respectively and recommended as one inhalation twice daily. This boosts the market growth

Opportunities

• Increasing Demand for Retail Pharmacies

Rise in the number of rhinitis therapeutics are delivered through retail pharmacies and rise in the number of retail pharmacies in developed countries create much opportunities for the market growth. In addition to this, patients select retail pharmacies for purchasing drugs, as these are easily accessible.

• Rising Healthcare Expenditure

Since the last few decades, it has been witnessed that global per capita healthcare spending has improved considerably due to rising rate of awareness associated with the availability of treatments and diagnostic methods for treating various diseases. More and more healthcare spending is likely to result in increasing demand for better diagnostic methods, which in turn, create high growth opportunities for market players operating in the treatment of allergic and asthmatic conditions in the global allergic asthma disease market.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global allergic asthma disease market over a forecast period.

• High Cost

The huge expenditure associated with the treatment of allergic asthma surely hamper the market growth.

This global allergic asthma disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global allergic asthma disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Allergic Asthma Disease Market Scope

The global allergic asthma disease market is segmented on the basis of drug class, route of administration , distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Inhaled Corticosteroids
• Anticholinergics
• Beta Agonists
• Others

Route of Administration

• Oral
• Inhalation
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Allergic Asthma Disease Market Regional Analysis/Insights

The global allergic asthma disease market is analysed and market size insights and trends are provided by drug class, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global allergic asthma disease market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global allergic asthma disease market throughout the forecasted period due to the presence of key generic pharmaceuticals companies in this region and rise in consumption of tobacco products.

North America dominates the market due to the high prevalence of asthma disease and large availability of treatment options.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 글로벌 알레르기 천식 질환 시장 점유율 분석

글로벌 알레르기 천식 질환 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 알레르기 천식 질환 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 알레르기성 천식 질환 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 파이저 주식회사(미국)
• 머크 KGaA(독일)
• 사노피(프랑스)
• 바이오케어 메디컬, LLC (미국)
• 릴리(미국)
• Teva Pharmaceutical Industries(이스라엘)
• 브리스톨-마이어스 스퀴브 회사(미국)
• GSK plc. (영국)
• Bayer AG(독일)
• Teva Pharmaceuticals Industries Ltd. (이스라엘)
• 릴리(미국)
• 아스트라제네카(영국)
• Sunovion Pharmaceuticals Inc. (미국)
• AbbVie Inc(미국)

SKU-53992